✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Sandu Pharmaceuticals Ltd.

SANDUPHQ

Market Cap
₹51 Cr.
P/E
32.63

Sandu Pharmaceuticals Ltd.

  • Sandu Pharmaceutical
  • Deccan Health Care
  • Bacil Pharma
FAQs on Sandu Pharmaceuticals Ltd. Shareprice

Sandu Pharmaceutical has given lower returns compared to its competitors.
Sandu Pharmaceutical has grown at ~-7.9% over the last 3yrs while peers have grown at a median rate of 39.07%

Sandu Pharmaceutical is not expensive.
Latest PE of Sandu Pharmaceutical is 32.63, while 3 year average PE is 36.54.
Also latest EV/EBITDA of Sandu Pharmaceutical is 17.56 while 3yr average is 18.77.

View FAQ's On Business
Growth Table
  • Sandu Pharmaceuticals Ltd.
  • Deccan Health Care
  • Bacil Pharma
Balance Sheet
  • Sandu Pharmaceuticals Ltd.
  • Deccan Health Care
  • Bacil Pharma
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Sandu Pharmaceuticals Ltd.
  • Deccan Health Care
  • Bacil Pharma
Cash Flow
  • Sandu Pharmaceuticals Ltd.
  • Deccan Health Care
  • Bacil Pharma
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Sandu Pharmaceuticals Ltd.
  • Deccan Health Care
  • Bacil Pharma
Quarterly Results
  • Sandu Pharmaceuticals Ltd.
  • Deccan Health Care
  • Bacil Pharma
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Sandu Pharmaceuticals Ltd. Financials

Balance sheet of Sandu Pharmaceutical is strong.
But short term working capital might become an issue for this company.

The net debt of Sandu Pharmaceutical is decreasing.
Latest net debt of Sandu Pharmaceutical is -₹2.65 Crs as of Mar-25.
This is less than Mar-24 when it was -₹2.38 Crs.

The profit is oscillating.
The profit of Sandu Pharmaceutical is ₹1.58 Crs for TTM, ₹1.46 Crs for Mar 2024 and ₹1.52 Crs for Mar 2023.

The company seems to pay a good stable dividend.
Sandu Pharmaceutical latest dividend payout ratio is 52.89% and 3yr average dividend payout ratio is 47.38%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech